BioNTech SEBNTXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+139.3%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+139.3%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
13.7x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 92.58% |
| Q2 2025 | 7.02% |
| Q1 2025 | -260.23% |
| Q4 2024 | 30.99% |
| Q3 2024 | 124.52% |
| Q2 2024 | -156.36% |
| Q1 2024 | -168.81% |
| Q4 2023 | 185.12% |
| Q3 2023 | 184.35% |
| Q2 2023 | -137.91% |
| Q1 2023 | -77.96% |
| Q4 2022 | 27.67% |
| Q3 2022 | 6.75% |
| Q2 2022 | -54.80% |
| Q1 2022 | 16.82% |
| Q4 2021 | -1.40% |
| Q3 2021 | 15.21% |
| Q2 2021 | 147.07% |
| Q1 2021 | 207.46% |
| Q4 2020 | 274.72% |
| Q3 2020 | -137.83% |
| Q2 2020 | -65.36% |
| Q1 2020 | 8.28% |
| Q4 2019 | -93.41% |
| Q3 2019 | 39.89% |
| Q2 2019 | -23.22% |
| Q1 2019 | -2906.36% |
| Q4 2018 | 94.23% |
| Q3 2018 | -101.70% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |